Beam Therapeutics Inc. (BEAM) vs Nurix Therapeutics, Inc. (NRIX)
- Beam Therapeutics Inc. BEAM 23.47 −5.10%
- Nurix Therapeutics, Inc. NRIX 24.42 −2.12%
Beam Therapeutics Inc. and Nurix Therapeutics, Inc. are both Biotechnology companies. Beam Therapeutics Inc. and Nurix Therapeutics, Inc. are of similar size ($2.7B and $2.6B). Beam Therapeutics Inc. has negative trailing earnings, so its P/E is not meaningful; Nurix Therapeutics, Inc. trades at 9.7×. Nurix Therapeutics, Inc. grew revenue faster over the last twelve months: 738.8% against 158.9%. Nurix Therapeutics, Inc. has the higher net margin (42.0% vs −55.5%) and the higher return on invested capital (0.00% vs −1,599.3%). Across the 17 metrics below, Nurix Therapeutics, Inc. leads on 13 and Beam Therapeutics Inc. on 4.
Valuation
Profitability
| Metric | BEAM | NRIX | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | (242.27%) | 41.27% | 0.00% |
| Net margin | (55.45%) | 42.01% | 0.00% |
| Free cash flow margin | (238.90%) | 52.68% | 0.00% |
| Return on equity | (8.18%) | 43.99% | (56.36%) |
| Return on assets | (6.23%) | 34.33% | (48.04%) |
| Return on invested capital | (1,599.30%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack